Prevalence, Risk Factors and Disease Knowledge of Polycystic Kidney Disease in Pakistan
Overview
Pathology
Pharmacology
Authors
Affiliations
Polycystic kidneys disease refers to cyst(s) formation in kidneys with severe consequences of end stage renal disease thus have higher mortality. It is a common genetic disease occurring either as autosomal dominant polycystic kidney (ADPKD) or autosomal recessive polycystic kidney disease (ARPKD) with prevalence rates of 1/1000 and 1/40,000 respectively. Dominant forms presenting in later (>30) while recessive in earlier ages (infancy) and affecting both sexes and almost all race. The patient experiences many renal as well as extra-renal manifestations with marked hypertension and cyst formation in other organs predominantly in liver. Due to genetic basis, positive family history is considered as major risk factor. Ultrasonography remains the main stay of diagnosis along with family history, by indicating increased renal size and architectural modifications. Initially disease remains asymptomatic, later on symptomatic treatment is suggested with surgical interventions like cyst decortications or drainage. Dialysis proved to be beneficial in end stage renal disease. However renal transplantation is the treatment of choice.
Determinants of Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
Kebede M, Mengistu Y, Loge B, Eshetu M, Shash E, Wirtu A J Pers Med. 2024; 14(9).
PMID: 39338190 PMC: 11433103. DOI: 10.3390/jpm14090936.
Djajapranata K, Tjempakasari A Narra J. 2024; 4(1):e584.
PMID: 38798842 PMC: 11125292. DOI: 10.52225/narra.v4i1.584.
Single-Center Experience of Pediatric Cystic Kidney Disease and Literature Review.
Grlic S, Gregurovic V, Martinic M, Davidovic M, Kos I, Galic S Children (Basel). 2024; 11(4).
PMID: 38671609 PMC: 11048964. DOI: 10.3390/children11040392.
Khan A, Anwar M, Zaidi F, Ghabsha S, Ur Rehman A Cureus. 2023; 15(7):e41537.
PMID: 37554616 PMC: 10404565. DOI: 10.7759/cureus.41537.